Trial intelligence / Profile preview

Bosentan and ocular blood flow in primary open-angle glaucoma

2006-003140-27Phase 4Completed

Sponsor
Department of Clinical Pharmacology
Start
Jul 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of bosentan in open-angle glaucoma (OAG) (2 arms), sponsored by Department of Clinical Pharmacology. Started Jul 2006; status: completed.

02

Drugs

bosentan
03

Conditions

open-angle glaucoma (OAG)

Beyond the preview

Go deeper on 2006-003140-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003140-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call